Line Item

Number of common shares

Income Statement
Abbott Laboratories
As of 31st December 2011
USD $ in millions
Description

Dec 31, 2011

Net sales
Cost of products sold

38,851,259
-15,540,580

Gross profit

23,310,679

Research and development

Acquired in-process and collaborations research and development
Selling, general and administrative

-4,129,414
-672,500
-12,756,817

Operating earnings
Interest expense
Interest income
Income from the TAP Pharmaceutical Products Inc. joint venture
Net foreign exchange gain (loss)
Other income (expense), net

Earnings from continuing operations before taxes

Taxes on earnings

Earnings from continuing operations

Gain on sale of discontinued operations, net of taxes

Net earnings

5,751,948
-530,141
85,196
0
50,271
-158,632

5,198,642
-470,193

4,728,449
0

4,728,449

Balance Sheet
Abbott Laboratories
As of 31st December 2011
USD $ in millions
Description
Cash and cash equivalents
Investments, primarily time deposits and certificates of deposit
Restricted funds, primarily U.S. treasury bills
Trade receivables, less allowances
Inventories
Deferred income taxes
Other prepaid expenses and receivables

Current assets
Investments
Net property and equipment
Intangible assets, net of amortization
Goodwill
Deferred income taxes and other assets

Noncurrent assets
Total assets

Short-term borrowings
Trade accounts payable
Salaries, wages and commissions
Accrued rebates payable to government agencies
Accrued other rebates
All other

Other accrued liabilities

Dividends payable
Income taxes payable
Obligation in connection with conclusion of the TAP Pharmaceutical Products Inc. joint venture
Current portion of long-term debt

Current liabilities
Long-term debt, excluding current portion
Defined benefit pension plans and post-employment medical and dental plans for significant plans
Deferred income taxes
All other

Post-employment obligations and other long-term liabilities

Noncurrent liabilities
Total liabilities
Preferred shares, one dollar par value, none issued
Common shares, without par value

Common shares held in treasury, at cost

Earnings employed in the business
Accumulated other comprehensive income (loss)

Abbott shareholders' investment

Noncontrolling interests in subsidiaries

Total shareholders' investment

Total liabilities and shareholders' investment

Dec 31, 2011

6,812,820
1,284,539
0
7,683,920
3,284,249
2,700,540
2,002,706

23,768,774
378,225
7,873,955
9,989,636
15,705,380
2,560,923

36,508,119
60,276,893

2,347,859
1,721,127
1,260,121
1,049,000
1,238,000
5,567,994

7,854,994
754,284
514,947
0
1,026,896

15,480,228
12,039,822
3,301,000
703,000
4,226,698

8,230,698
20,270,520
35,750,748
0
9,817,134

-3,687,478
20,907,362
-2,597,185

24,439,833
86,312

24,526,145
60,276,893

Definition:
Current Ratio

Current Assets
Current Liabilities

Quick Ratio

Total quick assets

Current Liabilities

Definition:
Return on Assets Ratio

Return on Equity Ratio

Gross Profit Margin Ratio

Operating Profit Margin Ratio

Net Profit Margin Ratio

Earnings per Share Ratio

Net Income
Average Total Assets

Net Income
Owners' Equity

Gross Profit
Net Sales

Operating Profit
Net Sales

Net Income
Net Sales

Net Income
Average Number of Common Shares

Definition:
1

Total Debt Ratio

Interest Coverage Ratio

Debt/Equity Ratio

Total Liabilities
Total Assets

Earnings Before Interest and Taxes

Interest Expense

Total Debt
Owners' Equity

Definition:
1

Inventory Turnover Ratio =

Total Assets Turnover

Ratio

Total Sales
Inventory

Total Sales
Total Assets